Urology Flashcards
Differentiate between the different types of hematuria
Pre-renal - coagulopathy - sickle cell disease - thromboembolism Renal - trauma - renal carcinoma - infection - glomerulonephritis Post-Renal (TITS) - Trauma: foreign body, catheritization, radiation - Infection - Tumour: bladder cancer, prostate hypertrophy - Stone: renal calculi
Differentiate between renal and post-renal hematuria
Renal - tea colored urine with no clots - high creatinine and BUN - dysmorphic RBC, RBC casts - proteinuria Post-Renal - red with some clots - normal creatinine - normal shaped RBC with no proteinuria
Discuss the presentation and management of renal cell carcinoma
Risk Factors - smoking - hypertension - obesity - kidney anomaly Presentation - asymptomatic with incidental finding on imaging - Triad of gross hematuria, flank pain, and palpable mass - paraneoplastic syndromes (hypercalcemia, anemia, erythrocytosis, hypertension) Investigation - CT - biopsy Management - partial or radical nephrectomy - radiotherapy - anti-angiogenesis factors, mTOR, IL-2 for advanced disease
Discuss the presentation and management of bladder cancer
- transitional cell carcinoma Risk Factors - smoking - chemical exposure - cyclophosphamide - radiation to pelvis - chronic bladder irritation Presentation - gross hematuria - pain - clot retention - FUNSHED Investigation - NMP-22, BTA, immunocyt and FDP are bladder tumour markers - cystoscopy with bladder washing Management - surperficial: transurethral resection of bladder tumour - invasive: cystectomy with chemo-radiation adjuvant (mitomycin)
Differentiate the different causes of failure to store
Urge Incontinence (detrusor overactivity or decreased compliance)
- detrusor overactivity from CNS lesion, inflammation, bladder neck obstruction
- decreased bladder compliance: fibrosis of bladder or non-functioning neck
Stress Incontinence (urethral hypermobility or instrinsic sphincter deficiency)
- urethral hypermobility: weakened pelvic floor from childbirth, pelvic surgery, age
- instrinsic sphincter weakness: aging, hypo-estrogen, pelvic surgery
Overflow Incontinence (due to failure to void)
Discuss the medications associated with incontinence
- anti-histamine
- anticholinergic
- ACE inhibitor
- Diuretic
- alpha agonist
Discuss the investigations and management of the types of incontinence
Urge
- diagnosis from urgency on history and urodynamics
- lifestyle modification and bladder habit training
- anti-cholinergics
- botox
Stress
- diagnosis past on history and positive stress test
- lifestyle modification with pelvic floor therapy
- pessary for females
- surgical sling, or sphincter
Overflow
- diagnosis from post-void residual of >200cc
- lifestyle management
- catheterization
- removal of obstruction
Differentiate the causes of urinary retention
Outflow Obstruction - urethra: stricture - bladder neck: stone, foreign body, neoplasm - prostate: BPH, cancer - external obstruction Neurogenic bladder - stroke, Parkinson's - spinal injury, MS - diabetic neuropathy Urinary Tract Irritation - UTI Medications - anticholinergics - narcotics - ephedrine
Discuss the urinary questions
FUNSHED
- Frequency
- Urgency
- Nocturia
- Straining
- Hesitancy
- Dysuria
Describe the 3 zones of the prostate
Peripheral zone
- 70% of volume and most common site of cancer (adenocarcinoma)
Central Zone
- 25% of volume and surround ejaculatory ducts
Peri-urethral transitional zone
- 5% and is site of BPH
Discuss the physiology and histology of the prostate gland
Physiology
- secrete thin, milky fluid which aids in sperm viability and motility
- prostate growth stimulated by andreogens (testosterone and dihydrotestosterone)
Histology
- formed by tubuloalveolar glands surrounded by fibromuscular strom
- line with simple columnar epithelium
- have corpora amylacea in prostatic gland
List the risk factors for prostate cancer
- African descent
- family history
- high dietary fat
- cigarette smoking
Discuss the presentation and management of prostate cancer
Presentation
- asymptomatic early so detected by DRE and PSA
- FUNSHED
- erectile dysfunction
- incontinence
- DRE demonstrate hard, irregular node or diffuse induration
- metastasis to bone (osteoblastic) in axial skeleton
Investigations
- PSA
- biopsy with tans-rectal ultrasound
- CT abdomen
Management
- watchful waiting for short life expectancy
- active surveillance for low grade disease
- brachytherapy for low risk disease
- external beam for locally advanced in older patients
- radical prostatectomy for young patients with high risk disease
- metastasis treat with antiandrogens
Discuss PSA screening
Elevation in PSA
- prostate cancer
- BPH
- prostatitis
- trauma from DRE, catheterization
PSA
- <10% free PSA than high risk for cancer
- >0.75ng/mL/yr velocity than increased risk of cancer
- >0.15ng/mL/g density than increased risk
- <4ug/L is normal (but varies with age and race)
Discuss the presentation and management of benign prostate hyperplasia
Presentation
- FUNSHED
- DRE demonstrate symmetrically enlarged, smooth prostate
Investigation
- post-void residual and urodynamics
Management
- mild symptoms have lifestyle changes of fluid restriction
- moderate use alpha-adrenergic antagonist to reduce stroma smooth muscle tone (tamsulosin (flomax)
- 5-alpha reductase inhibitor to inhibit conversion of testosterone to DHT (finasteride)
- Surgery TURP for renal failure, recurrant UTI/hematuria, urinary retention
Discuss the presentation and management of prostatitis
- most common urologic disease in men <50
- infection with PEEAKS bacteria
Risk Factors - BPH
- recent instrumentation of urinary tract
Presentation - FUNSHED with hematuria
- fever
- rectal, perineal pain
- DRE show tender, warm prostate
Investigation - 4 specimen urine culture
Management - septra PO for 4-6 weeks